IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $370,864 | +8.0% | 8,176 | -2.3% | 0.00% | – |
Q2 2023 | $343,461 | +14.7% | 8,371 | -0.1% | 0.00% | – |
Q1 2023 | $299,537 | -14.4% | 8,381 | -9.6% | 0.00% | – |
Q4 2022 | $350,014 | -19.5% | 9,267 | -5.7% | 0.00% | – |
Q3 2022 | $435,000 | +17.6% | 9,829 | -1.5% | 0.00% | – |
Q2 2022 | $370,000 | +3.4% | 9,982 | +3.3% | 0.00% | – |
Q1 2022 | $358,000 | +33.1% | 9,662 | +9.4% | 0.00% | – |
Q4 2021 | $269,000 | -8.5% | 8,831 | +0.4% | 0.00% | – |
Q3 2021 | $294,000 | -21.2% | 8,799 | -5.9% | 0.00% | – |
Q2 2021 | $373,000 | -11.2% | 9,347 | -0.1% | 0.00% | – |
Q1 2021 | $420,000 | -13.8% | 9,358 | +8.7% | 0.00% | – |
Q4 2020 | $487,000 | +20.2% | 8,606 | +0.8% | 0.00% | – |
Q3 2020 | $405,000 | -20.1% | 8,540 | -0.5% | 0.00% | -100.0% |
Q2 2020 | $507,000 | +25.2% | 8,585 | +0.0% | 0.00% | 0.0% |
Q1 2020 | $405,000 | -24.9% | 8,584 | -3.9% | 0.00% | 0.0% |
Q4 2019 | $539,000 | +7.4% | 8,933 | +6.4% | 0.00% | 0.0% |
Q3 2019 | $502,000 | -6.9% | 8,393 | +0.2% | 0.00% | 0.0% |
Q2 2019 | $539,000 | -19.2% | 8,378 | +2.0% | 0.00% | 0.0% |
Q1 2019 | $667,000 | +45.0% | 8,212 | -3.5% | 0.00% | 0.0% |
Q4 2018 | $460,000 | +4.1% | 8,512 | -0.5% | 0.00% | – |
Q3 2018 | $442,000 | +24.9% | 8,558 | +0.5% | 0.00% | – |
Q2 2018 | $354,000 | -5.3% | 8,513 | +0.6% | 0.00% | – |
Q1 2018 | $374,000 | -11.8% | 8,460 | +0.2% | 0.00% | – |
Q4 2017 | $424,000 | +1.2% | 8,441 | +2.3% | 0.00% | – |
Q3 2017 | $419,000 | 0.0% | 8,249 | +0.2% | 0.00% | – |
Q2 2017 | $419,000 | +18.4% | 8,229 | -6.6% | 0.00% | – |
Q1 2017 | $354,000 | -16.7% | 8,815 | -0.9% | 0.00% | – |
Q4 2016 | $425,000 | +46.6% | 8,897 | +12.9% | 0.00% | – |
Q3 2016 | $290,000 | +53.4% | 7,877 | -3.0% | 0.00% | – |
Q2 2016 | $189,000 | -64.1% | 8,120 | -37.6% | 0.00% | -100.0% |
Q1 2016 | $526,000 | -69.4% | 13,016 | -53.0% | 0.00% | -50.0% |
Q4 2015 | $1,717,000 | – | 27,711 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |